fbpx

Ep. 477: Perry Davidson, Syqe

Being able to quantify, harness, and ultimately control the psychoactive effects of cannabis is key in making cannabis accessible to as many patients as possible, according to Perry Davidson, founder and CEO of Syqe. When Davidson was first founding Syqe, he noticed that a majority of patients were using cannabis to treat their chronic pain, […]

Cannabinoid Report: Anandamide

N-Arachidonylethanolamine (familiarly known as anandamide, or AEA) was discovered in 1992 by Dr. Raphael Mechoulam and his team. Anandamide is an endogenous cannabinoid, which means that it is produced by the body rather than by the cannabis plant – anandamide is a derivative of the fatty acid arachidonic acid via an oxidative metabolic process. Our […]

Condition Report: Huntington’s Disease

OVERVIEW In 2017, the National Academies of Science, Engineering & Medicine released a comprehensive report, “The Health Effects of Cannabis & Cannabinoids”, based on the research that had been done to date. Following that valuable report, we’ve been providing weekly Condition Reports on 2018 research for each of the conditions cited in that report, such as […]

Ep. 476: Jeff Chen, UCLA

Jeff Chen, Director of the UCLA Cannabis Research Initiative, has learned that “the average physician really is, in many ways, powerless to navigate the healthcare system.” Because of this, Chen decided that the best way to change the system was to learn the business side of it as well. Chen also notes that, even today, […]

Q3 Podcast Highlights

Episode 445 – U.S. Congresswoman Eleanor Holmes Norton “The fact is that across this United States, the final verdict is in. So, Congress should just catch up. The police have caught up. You won’t find the police arresting people unless it’s out in the open, smoking almost in your face.” “I don’t believe that if […]

Q3 Column Highlights

Housing – U.S. Congressman Ro Khanna “Currently, rent control ordinances allow little security for renters. I’d like to repeal some of those laws, because our communities need reasonable rent control for its middle-class workers. We’re also working with HUD to allocate funding for public housing and affordable rent. We must continue to push for affordable housing.” […]

Cannabinoid Report: CBD (Part I)

Besides THC, Cannabidiol (CBD) is cannabis’s other most studied and well-known cannabinoid. However, unlike THC, CBD is not psychoactive; consuming pure CBD does not produce the same “high” feeling that THC does. CBD was discovered in 1940 and is just one of hundreds of cannabinoids found in the cannabis plant. Today, there is extensive information […]

Condition Report: Amyotrophic Lateral Sclerosis (ALS)

OVERVIEW In 2017, the National Academies of Science, Engineering & Medicine released a comprehensive report, “The Health Effects of Cannabis & Cannabinoids”, based on the research that had been done to date. Following that valuable report, we’ve been providing weekly Condition Reports on 2018 research for each of the conditions cited in that report, such as […]

Cannabinoid Report: CBT

Cannabitriol (CBT) is one of the minor cannabinoids found in the cannabis plant. CBT was first discovered in 1966 by Obata and Ishikawa, but its chemical structure was later determined by researchers in 1976. As of now, there are nine known types of CBT. CBT is not always present in cannabis, but when it is, […]

Condition Report: Tourette Syndrome

OVERVIEW In 2017, the National Academies of Science, Engineering & Medicine released a comprehensive report, “The Health Effects of Cannabis & Cannabinoids”, based on the research that had been done to date. Following that valuable report, we’ve been providing weekly Condition Reports on 2018 research for each of the conditions cited in that report, such as […]